Epo is expressed in response to hypoxia and upon binding to its transmembrane receptor on erythroid progenitor cells acts as an essential inhibitor of programmed cell death (PCD). Upstream effectors that dock at Epo-receptor complexes are relatively well defined (Jak2, Syp, HCP, STAT5, PLC-gamma, P13K, SHIP, Shc, Grb2, Crk-l, Cbl, Vav) and for many, links to mitogenic response pathways established. Yet, beyond the observations that EPO sustains Bcl-xl expression and protects against p53-induced PCD in a cell cycle phase-independent fashion, little is understood about effectors of PCD. Studies aim to advance an understanding of mechanisms of this key response.
Aim #1 : In Epo, SCF-, IL-3 dependent FDCW2 cell lines expressing EpoR deletion and point- mutants, the extend to which Epo-dependent pathways to P13K/Akt kinase activation and Bad phosphorylation (versus hypothesized alternative pathways) inhibit PCD will be studied. hEGFR-EpoR chimeras with defined mutations in cytoplasmic domains have been expressed in erythroid progenitor cells in transgenic mice. Using this novel in vivo model (and thiamphenicol to induced splenic CFUe) essential signals for PCD inhibition also will be investigated. In purified CFUe Bcl2-related, - associated factors whose expression is modulated by EPO also will be defined.
Aim #2 : Expression of Pim1 kinase is induced via minimal EpoR forms that efficiently inhibit PCD, and ectopically expressed Pim1 inhibits PCD. Based on these observations, mechanisms of Pim1-inhibited PCD will be investigated. Evidence for targets upstream of APAF1 will be sought; the ability of Pim1 to protect against PCD as induced by radiation, dexamethasone and/or Myc-induced PCD will be tested; and possible effects of Pim1 on the expression of Bcl2-associated, related factors will be studied. Also, cis-elements and transfactors that regulate Pim1 gene expression in response to Epo versus SCF will be investigated in folate-deficiency and Diamond-Blackfan anemias, erythroid failure is characterized by PCD and EpoR mutations are associated with erythrocytosis and polycythemias. Insight into regulation of PCD gained from studies of Epo signaling should extend to related clinically important cytokine systems.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK040242-11S1
Application #
6227339
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Badman, David G
Project Start
1988-04-01
Project End
2003-03-31
Budget Start
2000-04-01
Budget End
2001-03-31
Support Year
11
Fiscal Year
2000
Total Cost
$84,180
Indirect Cost
Name
Pennsylvania State University
Department
Veterinary Sciences
Type
Schools of Earth Sciences/Natur
DUNS #
City
University Park
State
PA
Country
United States
Zip Code
16802
Li, Ke; Miller, Chris; Hegde, Shailajia et al. (2003) Roles for an Epo receptor Tyr-343 Stat5 pathway in proliferative co-signaling with kit. J Biol Chem 278:40702-9
August, Avery; Fischer, Angela; Hao, Shengli et al. (2002) The Tec family of tyrosine kinases in T cells, amplifiers of T cell receptor signals. Int J Biochem Cell Biol 34:1184-9
Miller, Chris P; Heilman, Destin W; Wojchowski, Don M (2002) Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms. Blood 99:898-904
Li, Ke; Zhao, Shuqing; Karur, Vinit et al. (2002) DYRK3 activation, engagement of protein kinase A/cAMP response element-binding protein, and modulation of progenitor cell survival. J Biol Chem 277:47052-60
Geiger, J N; Knudsen, G T; Panek, L et al. (2001) mDYRK3 kinase is expressed selectively in late erythroid progenitor cells and attenuates colony-forming unit-erythroid development. Blood 97:901-10
Wojchowski, D M; Gregory, R C; Miller, C P et al. (1999) Signal transduction in the erythropoietin receptor system. Exp Cell Res 253:143-56
Seshasayee, D; Gaines, P; Wojchowski, D M (1998) GATA-1 dominantly activates a program of erythroid gene expression in factor-dependent myeloid FDCW2 cells. Mol Cell Biol 18:3278-88